Diabetes is one of the four major non-communicable diseases (NCDs) contributing to global morbidity and mortality. There are over 150 million Muslims with diabetes worldwide. So, Ramadan has a major impact on Diabetes management in the Muslim population.

Because Diabetes is a metabolic disease, drastic food and liquid intake changes can cause complications. The International Diabetes Federation (IDF) and the Diabetes and Ramadan International Alliance (DaR) have launched a guideline for the healthcare professionals to educate their patients about Diabetes management during the holy month of Ramadan.

Under this campaign, over 300 allied doctors will monitor patients' blood glucose levels and advise them on Diabetes management during Ramadan. The Bangladesh Endocrine Society (BES) will provide all necessary materials, including daily blood glucose monitoring books, diet and exercise plans, and medication adjustments. Sanofi Bangladesh - A subsidiary of Beximco Pharmaceuticals Limited is the scientific partner in this novel and patient centric initiative. Based on the patient data, BES will later formulate a real-world evidence-based guideline specifically for Bangladesh.

All Diabetic patients who want to fast must consult their respective doctors, find out what to do to fast. Because, during the month of Ramadan, there will be differences in the lifestyle and, as a result, and changes in the intake of medicine for diabetic patients. So, it is important to educate the patients about the changed condition.